• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Asia-Pacific Respiratory Device Industry Insights, 2019-2025 – Key Players are ResMed, Cipla, GlaxoSmithKline, 3M, Novartis, and Omron Healthcare

Share:

April 20, 2020

The Asia-Pacific respiratory device market was valued at around $6.1 billion in 2018 and is estimated to grow at a CAGR of around 6.7% during the forecast period.

The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in North America. The Asia-Pacific respiratory devices market presents future opportunities for growth as the prevalence of respiratory diseases such as asthma and COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.

The Asia-Pacific respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the regional market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include ResMed Corp., Cipla Ltd., GlaxoSmithKline PLC, 3M Co., Novartis AG, Omron Healthcare Inc., and others. The market players are adopting the strategy of merger & acquisition, product launch and expansion of their manufacturing facilities to increase their market share. For instance, In January 2018 Omron Healthcare Introduces Avail, a Wireless Device for Drug-Free Pain Relief. In January 2019 Omron Healthcare officially launches HeartGuide the first wearable blood pressure monitor, with new digital health service, HeartAdvisor.

The Report Covers:

  • A comprehensive research methodology of the Asia-Pacific respiratory device market.
  • A detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific respiratory device market.
  • Insights about market determinants which are stimulating the Asia-Pacific respiratory device market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Read more

Source: Benzinga

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cytocom Inc. Announces Completed Merger with Cleveland BioLabsCytocom Inc. Announces Completed Merger with Cleveland BioLabs
  • Carenet Healthcare Services Acquires HGS AxisPoint Health Nurse Advice Line ServicesCarenet Healthcare Services Acquires HGS AxisPoint Health Nurse Advice Line Services
  • Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-Oncology PortfolioBoehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-Oncology Portfolio
  • Medical device co Inmode seeks $75m in Nasdaq IPOMedical device co Inmode seeks $75m in Nasdaq IPO
  • The Race For AI: Here Are The Tech Giants Rushing To Snap Up Artificial Intelligence StartupsThe Race For AI: Here Are The Tech Giants Rushing To Snap Up Artificial Intelligence Startups
  • 23andMe Scores $82.5M, After a Difficult Year23andMe Scores $82.5M, After a Difficult Year
  • Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.Therapix Biosciences Provides Update on Planned Merger with Destiny Biosciences Global Corp.
  • Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare ConferencesMolecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences

Trending This Week

  • New tools and acquisitions from OptumRx, ScionHealth.
  • In the wake of Dobbs, women’s health is ‘Ripe for investment’
  • Market Skeptical Following Sen. Warren’s Antitrust Allegations
  • Rogers, Shaw tick lower amid a report that Industry Minister in no hurry to Ok deal
  • ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, furthering its Ambition to Become the Global Leader in Regenerative Therapies
  • Nemaura Enters into Letter of Intent to Acquire Healthimation, LLC to Augment proBEAT™ Launch in the U.S.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications